{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:25:37Z","timestamp":1790767537683,"version":"4.1.0"},"reference-count":83,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Special areas of involvement in psoriasis include the scalp region, the palms and soles, genital areas, as well as intertriginous sites. The involvement of these topographical regions is associated with important physical and emotional implications, resulting in reduced quality of life, social isolation, and work disability. Palms and soles can be affected as part of the generalized form of psoriasis or can be exclusively affected as palmo-plantar psoriasis. Nail involvement may be encountered in 10\u201355% of patients with psoriasis, while scalp involvement occurs in 45\u201356% of individuals with psoriasis. Genital involvement may be the only manifestation of cutaneous psoriasis in 2\u20135% of patients. Inverse or intertriginous psoriasis represents a special variant of psoriasis as it may mimic and be difficult to differentiate from other dermatological entities that involve the intertriginous skin, such as bacterial or fungal infections, eczema, or lichen planus. Treatment of psoriasis in special areas is challenging due to the facts that special areas are more resistant to standard therapies and are more sensitive to potent local treatments. Biological therapies, proven to be more efficient than standard therapies, are not widely available in the absence of extensive skin involvement. This manuscript aims to provide an up-to-date literature review on psoriasis in special areas, benefiting the everyday clinical practice of physicians in optimizing the evaluation and treatment of their patients.<\/jats:p>","DOI":"10.3390\/jcm13247549","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T12:50:08Z","timestamp":1733921408000},"page":"7549","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Updates on Psoriasis in Special Areas"],"prefix":"10.3390","volume":"13","author":[{"given":"Alexandra-Irina","family":"Butacu","sequence":"first","affiliation":[{"name":"2nd Department of Dermatology, Colentina Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4396-8081","authenticated-orcid":false,"given":"Cristian","family":"Toma","sequence":"additional","affiliation":[{"name":"3rd Department of Urology, \u201cProf. Dr. Theodor Burghele\u201d Clinical Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia-Elena","family":"Negulet","sequence":"additional","affiliation":[{"name":"2nd Department of Dermatology, Colentina Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionela","family":"Manole","sequence":"additional","affiliation":[{"name":"2nd Department of Dermatology, Colentina Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Nina","family":"Banica","sequence":"additional","affiliation":[{"name":"2nd Department of Dermatology, Colentina Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Plesea","sequence":"additional","affiliation":[{"name":"2nd Department of Dermatology, Colentina Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana Alexandra","family":"Badircea","sequence":"additional","affiliation":[{"name":"2nd Department of Dermatology, Colentina Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Iancu","sequence":"additional","affiliation":[{"name":"2nd Department of Dermatology, Colentina Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8719-6952","authenticated-orcid":false,"given":"George-Sorin","family":"Tiplica","sequence":"additional","affiliation":[{"name":"2nd Department of Dermatology, Colentina Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Dasc\u0103lu, R.C., B\u0103rbulescu, A.L., Stoica, L.E., Dinescu, \u0218.C., Bi\u021b\u0103, C.E., Popoviciu, H.V., Ionescu, R.A., and Vreju, F.A. (2024). Review: A Contemporary, Multifaced Insight into Psoriasis Pathogenesis. J. Pers. Med., 14.","DOI":"10.3390\/jpm14050535"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Rendon, A., and Sch\u00e4kel, K. (2019). Psoriasis Pathogenesis and Treatment. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061475"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5114\/reum.2018.80718","article-title":"Psoriasis in special localizations","volume":"56","author":"Dopytalska","year":"2018","journal-title":"Reumatologia"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Radaschin, D.S., Tatu, A., Iancu, A.V., Beiu, C., and Popa, L.G. (2024). The Contribution of the Skin Microbiome to Psoriasis Pathogenesis and Its Implications for Therapeutic Strategies. Medicina, 60.","DOI":"10.3390\/medicina60101619"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Radaschin, D.S., Iancu, A.V., Ionescu, A.M., Gurau, G., Niculet, E., Bujoreanu, F.C., Beiu, C., Tatu, A.L., and Popa, L.G. (2024). Comparative Analysis of the Cutaneous Microbiome in Psoriasis Patients and Healthy Individuals\u2014Insights into Microbial Dysbiosis: Final Results. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910583"},{"key":"ref_6","unstructured":"Miceli, A., and Schmieder, G.J. (2022). Palmoplantar Psoriasis. StatPearls, StatPearls Publishing."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4103\/0378-6323.84071","article-title":"Palmoplantar involvement in psoriasis: A clinical study","volume":"77","author":"Khandpur","year":"2011","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e23828","DOI":"10.1097\/MD.0000000000023828","article-title":"Analysis of dermoscopic characteristic for the differential diagnosis of palmoplantar psoriasis and palmoplantar eczema","volume":"100","author":"Yu","year":"2021","journal-title":"Medicine"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Broggi, G., Failla, M., Palicelli, A., Zanelli, M., and Caltabiano, R. (2022). Palmoplantar Psoriasis: A Clinico-Pathologic Study on a Series of 21 Cases with Emphasis on Differential Diagnosis. Diagnostics, 12.","DOI":"10.3390\/diagnostics12123071"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"T33","DOI":"10.1016\/j.ad.2022.07.025","article-title":"Quality of Life and Body Region Affected by Psoriasis: A Systematic Review","volume":"114","author":"Nabieva","year":"2023","journal-title":"Actas Dermosifiliogr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clindermatol.2016.09.004","article-title":"Palmoplantar psoriasis","volume":"35","author":"Engin","year":"2017","journal-title":"Clin. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/ijd.IJD_539_16","article-title":"Evidence and suggested therapeutic approach in psoriasis of difficult-to-treat areas: Palmoplantar psoriasis, nail psoriasis, scalp psoriasis, and Intertriginous psoriasis","volume":"62","author":"Sarma","year":"2017","journal-title":"Indian J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jaad.2023.04.043","article-title":"Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-analysis of randomized clinical trials","volume":"89","author":"Spencer","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Gisondi, P., Bellinato, F., and Girolomoni, G. (2020). Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113594"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e12589","DOI":"10.1111\/dth.12589","article-title":"Underdiagnosed and undertreated psoriasis: Nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails","volume":"31","author":"Merola","year":"2018","journal-title":"Dermatol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1111\/jdv.12004","article-title":"Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: A prospective, randomized study","volume":"27","author":"Janagond","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3889\/oamjms.2017.080","article-title":"Pustular Palmoplantar Psoriasis Successfully Treated with Nb-UVB Monochromatic Excimer Light: A Case-Report","volume":"5","author":"Gianfaldoni","year":"2017","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_18","first-page":"e17434","article-title":"Palmoplantar Psoriasis Successfully Treated With Risankizumab","volume":"13","author":"Alajlan","year":"2021","journal-title":"Cureus"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaad.2019.01.066","article-title":"Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study","volume":"80","author":"Mrowietz","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"St\u00e4nder, S., Syring, F., Ludwig, R.J., and Tha\u00e7i, D. (2020). Successful Treatment of Refractory Palmoplantar Pustular Psoriasis With Apremilast: A Case Series. Front. Med., 7.","DOI":"10.3389\/fmed.2020.543944"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e15253","DOI":"10.1111\/dth.15253","article-title":"Apremilast for the treatment of palmo-plantar non-pustular psoriasis: A real-life single-center retrospective study","volume":"35","author":"Pavia","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/jdv.16124","article-title":"Long-term efficacy and safety of secukinumab in the treatment of the multiple manifestations of psoriatic disease","volume":"34","author":"Reich","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/jdv.14237","article-title":"Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: Results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3)","volume":"31","author":"Menter","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Galluzzo, M., Talamonti, M., Cioni, A., Maffei, V., Shumak, R.G., Tofani, L., Bianchi, L., and Campione, E. (2022). Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11092631"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e14144","DOI":"10.1111\/dth.14144","article-title":"Efficacy and safety of risankizumab in psoriasis patients who failed anti-IL-17, anti-12\/23 and\/or anti IL-23: Preliminary data of a real-life 16-week retrospective study","volume":"33","author":"Megna","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1080\/09546634.2022.2081655","article-title":"Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: Results from an Italian 28-week retrospective study","volume":"33","author":"Megna","year":"2022","journal-title":"J. Dermatol. Treat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1080\/1744666X.2023.2272049","article-title":"Efficacy of biologic agents for palmoplantar psoriasis: A systematic review and network meta-analysis","volume":"19","author":"Tsiogkas","year":"2023","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3899\/jrheum.201471","article-title":"Nail Psoriasis: Diagnosis, Assessment, Treatment Options, and Unmet Clinical Needs","volume":"48","author":"Kaeley","year":"2021","journal-title":"J. Rheumatol."},{"key":"ref_29","unstructured":"Muneer, H., and Masood, S. (2022). Psoriasis of the Nails. StatPearls, StatPearls Publishing."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ad.2022.01.032","article-title":"Nail Psoriasis","volume":"113","author":"Puig","year":"2022","journal-title":"Actas Dermosifiliogr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000538581","article-title":"Dermoscopic Nail Changes in Psoriasis, Lichen Planus, and Lichen Striatus","volume":"10","author":"Starace","year":"2024","journal-title":"Skin. Appendage Disord."},{"key":"ref_32","unstructured":"Muneer, H., Sathe, N.C., and Masood, S. (2024). Nail Psoriasis. StatPearls, StatPearls Publishing."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jaad.2023.11.024","article-title":"Nail psoriasis and nail liche-planus: Updates on diagnosis and management","volume":"90","author":"Hwang","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/S0190-9622(03)00910-1","article-title":"Nail Psoriasis Severity Index: A useful tool for evaluation of nail psoriasis","volume":"49","author":"Rich","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_35","first-page":"123","article-title":"The modified Nail Psoriasis Severity Index: Validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis","volume":"34","author":"Bieber","year":"2007","journal-title":"J. Rheumatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/bjd.12664","article-title":"Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): Development and validation of a tool for assessment of nail psoriasis outcomes","volume":"170","author":"Augustin","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/jdv.17387","article-title":"Development and validation of the Physician\u2019s Global Assessment of Fingernail Psoriasis","volume":"35","author":"Hudgens","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/annrheumdis-2020-eular.2426","article-title":"AB0735 Severity of nail psoriasis score (snaps) demonstrates longitudinal construct validity against the modified nail psoriasis severity index (mnapsi) in an observational cohort of patients with psoriatic arthritis","volume":"79","author":"Antony","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.36849\/JDD.4969","article-title":"Treatment of Nail Psoriasis","volume":"21","author":"Kassir","year":"2022","journal-title":"J. Drugs Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2147\/CCID.S417679","article-title":"Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments","volume":"16","author":"Battista","year":"2023","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaad.2016.11.041","article-title":"Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator-controlled VOYAGE 1 trial","volume":"76","author":"Blauvelt","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/bjd.19509","article-title":"A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial","volume":"184","author":"Blauvelt","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/09546634.2020.1749546","article-title":"Efficacy of brodalumab in the treatment of scalp and nail psoriasis: Results from three phase 3 trials","volume":"33","author":"Elewski","year":"2022","journal-title":"J. Dermatolog Treat."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Hagino, T., Onda, M., Saeki, H., Fujimoto, E., and Kanda, N. (2024). Effectiveness of bimekizumab for genital, nail, and scalp lesions with psoriasis: A 24-week real-world study. J. Dermatol., Epub ahead of print.","DOI":"10.1093\/ced\/llae312"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaad.2015.09.001","article-title":"Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)","volume":"74","author":"Rich","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000517516","article-title":"Diagnostic Accuracy of Trichoscopy in Inflammatory Scalp Diseases: A Systematic Review","volume":"238","author":"Rudnicka","year":"2022","journal-title":"Dermatology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/jdv.17354","article-title":"Clinical and trichoscopic features in various forms of scalp psoriasis","volume":"35","author":"Bruni","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/PTT.S85330","article-title":"Management of scalp psoriasis: Current perspectives","volume":"6","author":"Gooderham","year":"2016","journal-title":"Psoriasis"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1684\/ejd.2011.1370","article-title":"Videodermoscopy scalp psoriasis severity index (VSCAPSI): A useful tool for evaluation of scalp psoriasis","volume":"21","author":"Rossi","year":"2011","journal-title":"Eur. J. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"68330","DOI":"10.1007\/s11356-021-15307-1","article-title":"Adverse impact of occupational exposure on Laborers of cement industry have scalp psoriasis and Pityriasis amiantacea with deficiency of zinc and selenium: Impact of mineral supplement","volume":"28","author":"Kazi","year":"2021","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"427","DOI":"10.5021\/ad.2016.28.4.427","article-title":"Histopathological Differential Diagnosis of Psoriasis and Seborrheic Dermatitis of the Scalp","volume":"28","author":"Park","year":"2016","journal-title":"Ann. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s13555-021-00521-z","article-title":"Scalp Psoriasis: A Literature Review of Effective Therapies and Updated Recommendations for Practical Management","volume":"11","author":"Mosca","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"833","DOI":"10.36849\/JDD.6498","article-title":"Treatment of Scalp Psoriasis","volume":"21","author":"Ghafoor","year":"2022","journal-title":"J. Drugs Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e15228","DOI":"10.1111\/dth.15228","article-title":"Anti-IL17 and anti-IL23 biologic drugs for scalp psoriasis: A single-center retrospective comparative study","volume":"35","author":"Narcisi","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/09546634.2020.1770167","article-title":"Biologics and small molecules in patients with scalp psoriasis: A systematic review","volume":"33","author":"Alsenaid","year":"2022","journal-title":"J. Dermatol. Treat."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Piaserico, S., Riedl, E., Pavlovsky, L., Vender, R.B., Mert, C., Tangsirisap, N., Haustrup, N., Gallo, G., Schuster, C., and Brunner, P.M. (2023). Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: Week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO). Front. Med., 10.","DOI":"10.3389\/fmed.2023.1185523"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/ijd.ijd_754_21","article-title":"Genital Psoriasis: A Prospective, Observational, Single-Centre Study on Prevalence, Clinical Features, Risk Factors, and Its Impact on Quality of Life and Sexual Health","volume":"67","author":"Yi","year":"2022","journal-title":"Indian. J. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000523818","article-title":"A Case of Male Genital Psoriasis without Involvement of the Glans Penis","volume":"14","author":"Zubrzycki","year":"2022","journal-title":"Case Rep. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1111\/jdv.16723","article-title":"Dermoscopy of genital diseases: A review","volume":"34","author":"Lacarrubba","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.det.2018.05.013","article-title":"Dermoscopy of Inflammatory Genital Diseases: Practical Insights","volume":"36","author":"Borghi","year":"2018","journal-title":"Dermatol. Clin."},{"key":"ref_61","first-page":"793","article-title":"The Static Physician\u2019s Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Psoriasis","volume":"16","author":"Merola","year":"2017","journal-title":"J. Drugs Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13555-017-0213-2","article-title":"The Development of a Patient-Reported Outcome Measure for Assessment of Genital Psoriasis Symptoms: The Genital Psoriasis Symptoms Scale (GPSS)","volume":"8","author":"Gottlieb","year":"2018","journal-title":"Dermatol. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/jdv.18102","article-title":"2021 European guideline for the management of vulval conditions","volume":"36","author":"Boffa","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s13555-018-0257-y","article-title":"Treatment of Genital Psoriasis: A Systematic Review","volume":"8","author":"Beck","year":"2018","journal-title":"Dermatol. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/ajd.14227","article-title":"Adult genital psoriasis: An updated review for clinicians","volume":"65","author":"Wu","year":"2024","journal-title":"Australas. J. Dermatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1111\/jdv.17836","article-title":"Ixekizumab provides persistent improvements in health-related quality of life and the sexual impact associated with moderate-to-severe genital psoriasis in adult patients during a 52-week, randomised, placebo-controlled, phase 3 clinical trial","volume":"36","author":"Ryan","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/14712598.2021.1843629","article-title":"A Randomized Controlled Ixekizumab Vs Secukinumab Trial to Study the Impact on Sexual Activity in Adult Patients with Genital Psoriasis","volume":"21","author":"AlMutairi","year":"2021","journal-title":"Expert. Opin. Biol. Ther."},{"key":"ref_68","first-page":"9692","article-title":"Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: A single-center retrospective comparative study","volume":"15","author":"Cortese","year":"2023","journal-title":"Dermatol. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2147\/CCID.S189000","article-title":"Inverse Psoriasis: From Diagnosis to Current Treatment Options","volume":"12","author":"Micali","year":"2019","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.clindermatol.2015.04.007","article-title":"Psoriasis inversa: A separate identity or a variant of psoriasis vulgaris?","volume":"33","author":"Omland","year":"2015","journal-title":"Clin. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40272-015-0137-1","article-title":"Psoriasis in children and adolescents: Diagnosis, management and comorbidities","volume":"17","author":"Bronckers","year":"2015","journal-title":"Paediatr. Drugs"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1111\/bjd.17649","article-title":"Image gallery: Reproduction of the auspitz sign by videodermatoscopy, confocal microscopy and horizontal histopathology","volume":"180","author":"Nasca","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_73","first-page":"176","article-title":"Clinical analysis of 48 of inverse psoriasis: A hospital-based study","volume":"15","author":"Wang","year":"2005","journal-title":"Eur. J. Dermatol."},{"key":"ref_74","first-page":"1011","article-title":"Shedding light on the \u201chidden psoriasis\u201d: A pilot study of the Inverse Psoriasis Burden of Disease (IPBOD) questionnaire","volume":"15","author":"Cohen","year":"2016","journal-title":"J. Drugs Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.0105-1873.2004.00444.x","article-title":"The vulvar epithelium differs from the skin: Implications for cutaneous testing to address topical vulvar exposures","volume":"51","author":"Farage","year":"2004","journal-title":"Contact Dermat."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s13555-021-00536-6","article-title":"Genital and Inverse\/Intertriginous Psoriasis: An Updated Review of Therapies and Recommendations for Practical Management","volume":"11","author":"Hong","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaad.2004.07.011","article-title":"Tacrolimus ointment is effective for facial and intertriginous psoriasis","volume":"51","author":"Lebwohl","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities","volume":"80","author":"Elmets","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_79","first-page":"37","article-title":"Use of topical coal tar foam for the treatment of psoriasis in difficult-to-treat areas","volume":"3","author":"Zeichner","year":"2010","journal-title":"J. Clin. Aesthetic Dermatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ccr3.2759","article-title":"Effective use of oral tofacitinib and phototherapy in a patient with concomitant alopecia areata, vitiligo, and plaque and inverse psoriasis","volume":"8","author":"Tajalli","year":"2020","journal-title":"Clin. Case Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"adv00006","DOI":"10.2340\/00015555-3353","article-title":"Ixekizumab results in persistent clinical improvement in moderate-to-severe genital psoriasis during a 52 week, randomized, placebo-controlled, phase 3 clinical trial","volume":"100","author":"Guenther","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_82","first-page":"21","article-title":"A case of inverse psoriasis successfully treated with adalimumab","volume":"23","year":"2014","journal-title":"Acta Dermatovenerol. Alp. Pannonica Adriat."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"bcr2016215019","DOI":"10.1136\/bcr-2016-215019","article-title":"Inverse psoriasis treated with ustekinumab","volume":"2016","author":"Campos","year":"2016","journal-title":"BMJ Case Rep."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7549\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:52:38Z","timestamp":1760115158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":83,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["jcm13247549"],"URL":"https:\/\/doi.org\/10.3390\/jcm13247549","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,11]]}}}